MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    STN-DBS Frequency Effects in Parkinson’s: An fMRI Study

    A. Vijayakumari, C. Piccinin, J. Alberts, P. Bhattacharya, M. Lowe, B. Walter (Cleveland, USA)

    Objective: The study aimed to investigate the impact of deep brain stimulation (DBS) at varying frequencies on brain activation patterns during a motor (force-tracking [FT])…
  • 2024 International Congress

    Bioreactor-produced iPSCs-derived Dopaminergic Neuron-containing Neural Microtissues Innervate and Restore Motor Function in a Dose-dependent Manner in a Parkinson Rat Model

    N. Prudon, L. Cordero-Espinoza, M. Abarkan, B. Gurchenkov, C. Morel, M. Lepleux, V. de Luca, N. Pujol, L. Milvoy, P. Morand, F. Moncaubeig, H. Wurtz, L. Poinçot, M. Demarco, A. Jonckeau, J. Plétenka, E. Luquet, K. Schmit, L. Piouceau, S. Guilbert, L. Manache-Alberici, M. Lanero, G. Dabee, T. Dufourd, J. Schroeder, K. Alessandri, E. Bezard, E. Faggiani, M. Feyeux (Bordeaux, France)

    Objective: To demonstrate the efficacy of a ready-to-graft 3D neural microtissue product – manufactured at large scale – as a therapeutically viable option to treat Parkinson’s…
  • 2024 International Congress

    Early changes in the locus coeruleus in mild cognitive impairment with Lewy bodies

    I. Rektorova, Z. Zeleznikova, L. Brabenec, K. Mitterova, L. Novakova (Brno, Czech Republic)

    Objective: To evaluate NMS signal changes in the locus coeruleus (LC) in mild cognitive impairment with Lewy bodies (MCI-LB) as compared to healthy controls (HC)…
  • 2024 International Congress

    Development and Feasibility Trial of iSupport-PD, a Digital intervention for carers of people with Parkinson’s and Cognitive Impairment

    A. Hand, J. Slodkowska-Barabasz, J. Milne, A. Mccarthy, K. Greenwell (Newcastle-upon-Tyne, United Kingdom)

    Objective: Develop a digital intervention to prevent or decrease the mental and physical health problems associated with caring and improve quality of life of carers…
  • 2024 International Congress

    Clinical and neuroimaging factors associated with survival in Multiple System Atrophy

    G. Martí-Andrés, E. Prieto-Azcárate, CA. Espinoza-Vinces, M. Riverol, J. Arbizu, MR. Luquin-Puido (Pamplona, Spain)

    Objective: To assess clinical and neuroimaging factors associated with survival in a cohort of patients with a final clinical diagnosis of Multiple System Atrophy (MSA)…
  • 2024 International Congress

    Identification of Brain Atrophy Subtypes in Prodromal and Overt Synucleinopathies: A Multicenter Study

    S. Joza, A. Delva, C. Tremblay, A. Vo, J-F. Gagnon, R. Postuma, P. Dusek, M. Hu, J. Klein, J-P. Taylor, J. O'Brien, M. Firbank, A. Thomas, P. Donaghy, S. Lehericy, I. Arnulf, M. Vidailhet, J-C. Corvol, M. Sommerauer, S. Röttgen, S. Lewis, E. Matar, K. Ehgoetz Martens, L. Churchill, R. Camicioli, H. Chertkow, P. Borghammer, K. Knudsen, A. Hansen, D. Arnaldi, B. Orso, P. Matiioli, A. Dagher, S. Rahayel (Montreal, Canada)

    Objective: To identify unique subtypes of synucleinopathy with distinct spatiotemporal patterns and trajectories of brain atrophy and disease burden. Background: The synucleinopathies manifest as a…
  • 2024 International Congress

    From Images to Insights: Subtyping Parkinson’s Disease Using Unsupervised Learning on MRI Data

    D. Teixeira-Dos-Santos, A. De-Oliveira-Franco, A. Bieger, C. Mattjie, F. Suzuki, G. Magalhães Pereira, J. Rossi Catao, L. Angi Souza, L. Silveira Kupssinskü, L. Vinícius Moura, MA. Machado Schlindwein, R. Ravazio, S. Duarte Pinto, T. Hugentobler Schlickmann, E. R. Zimmer, MA. de Bastiani, R. C. Barros, AF. Schumacher Schuh (Porto Alegre, Brazil)

    Objective: To explore the heterogeneity of Parkinson's disease (PD) using unsupervised clustering of neuroimaging data, aiming to identify distinct subtypes based on volumetric features. Background:…
  • 2024 International Congress

    Minimally Clinical Important Differences of Hemifacial Spasm Score-30 (HFS-30) and Hemifacial Spasm Score-7 (HFS-7) for Patients with Hemifacial spasm

    N. Inthapong, W. Saengphatrachai, Y. Pitakpatapee, N. Rattanathamsakul, P. Sirvanitchapoom (Bangkok, Thailand)

    Objective: We aimed to estimate the MCIDs of HFS-30 and HFS-7, and factors associated with the MCID along with baseline and change score of HFS-30…
  • 2024 International Congress

    A 3D CNN Approach for the Classification of Multiple System Atrophy using Multimodal Multicentric MRI

    GM. Mattia, L. Chougar, WG. Meissner, A. Foubert-Samier, A. Pavy-Le Traon, O. Rascol, M. Fabbri, S. Lehéricy, P. Péran (Toulouse, France)

    Objective: To automatically distinguish between healthy controls (HC) and patients with multiple system atrophy (MSA) with a completely automatic approach using a 3D convolutional neural…
  • 2024 International Congress

    First in vivo evidence of the role of the noradrenergic system in olfactory dysfunction in Parkinson’s disease

    C. Laurencin, S. Lancelot, S. Brosse, J. Redouté, I. Mérida, D. Le Bars, N. Costes, S. Thobois, P. Boulinguez, B. Ballanger (lyon, France)

    Objective: To investigate the relationship between in vivo noradrenergic markers and olfactory impairment in patients with Parkinson’s disease (PD). Background: Degeneration of the noradrenergic (NA)…
  • « Previous Page
  • 1
  • …
  • 99
  • 100
  • 101
  • 102
  • 103
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley